Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 7,448 shares at $80.77 ($599K) on 2022-02-07, disclosed to the SEC on 2022-02-09.
Open-market sale of $599k NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.77 | 1,623 | $131K | 21.9% |
| 2 | $80.77 | 1,623 | $131K | 21.9% |
| 3 | $80.80 | 1,121 | $91K | 15.1% |
| 4 | $80.80 | 1,121 | $91K | 15.1% |
| 5 | $79.52 | 980 | $78K | 13.0% |
| 6 | $79.52 | 980 |
| $78K |
| 13.0% |
| Total | $80.45 avg | 7,448 | $599K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |